Skip to main content
Premium Trial:

Request an Annual Quote

IRBM Science Park Licenses Dotmatics' Cheminformatics Suite

Premium

Dotmatics said this week that IRBM Science Park, a spinoff from Merck Research Laboratories in Rome, Italy, has licensed its bioinformatics suite to support its cheminformatics research efforts.

The suite includes tools to for structure-activity relationship analysis, chemical informatics, data capture, compound sourcing, and biochemical data management. IRBM Science Park researchers will use the solution to register, query, browse, analyze, and visualize project information.

Alberto Bresciani, head of screening technologies at IRBM Science Park, said the Dotmatics suite provides "a unified platform" that can "efficiently manage scientific data" across diverse projects.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more